510(k) K992127

CARDIOQUANT TROPONIN I TEST by Spectral Diagnostics, Inc. — Product Code MMI

K992127 is an FDA 510(k) premarket notification submitted by Spectral Diagnostics, Inc. for the device "CARDIOQUANT TROPONIN I TEST". The FDA issued a decision of Substantially Equivalent on Oct 4, 1999. The device falls under product code MMI (Immunoassay Method, Troponin Subunit), a Class II device regulated under 21 CFR 862.1215. Spectral Diagnostics, Inc. has 11 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 4, 1999
Date Received
Jun 23, 1999
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Immunoassay Method, Troponin Subunit
Device Class
Class II
Regulation Number
862.1215
Review Panel
CH
Submission Type
510(k)

Need the full FDA record for Spectral Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K992127. Report a data issue: hello@regdatalab.com.